Gilead Sciences (GILD) Tops Q4 EPS by 17c; Guides
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $138.14 --0%
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Interest and other income, net: 119M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q4 EPS of $1.67, $0.17 better than the analyst estimate of $1.50. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $6.66 billion.
GUIDANCE:
Gilead Sciences sees FY2023 EPS of $6.60-$7.00, versus the consensus of $6.73. Gilead Sciences sees FY2023 revenue of $26-26.5 billion, versus the consensus of $27 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
